In Washington, researchers used blood from a National Children’s Study biobank to identify more accurate reference intervals for various hormones and amino acids in newborns across a diverse population. The more defined reference intervals could help with earlier diagnosis of diseases like diabetes and pediatric cancer as well as lead to a better understanding of physical and neurological development. As we know, newborns are tiny and its often difficult to draw a significant amount of blood from them for testing, which has proven to be a challenge in the past for researchers to have enough blood to test and reference. The hope is with this research, doctors will have a more accurate reference interval to refer to when testing pediatric patients for developmental issues or diseases.
Latest article
Fin-ished, for now: Aqua Cultured Foods shutters as funding dries up
In Chicago, a fermentation startup converting cellulose into seafood alternatives has wound down operations after failing to raise funds necessary to reach commercialization.
Established...
Mercedes unveils vegan-interior SUV at CES
In Nevada, Mercedes-Benz has showcased a new, vegan-interior GLC electronic SUV at the recent CES technology trade show in Las Vegas.
Vegan materials were...
Futerro files permits for French PLA site
In France, biobased chemicals maker Futerro has requested the relevant permits for its planned lactic acid and polylactic acid plant in France.
The plant, which...